In purified CD133+ liver cancer stem cells, knockdown of YTHDF2 impaired tumor-initiating ability; in contrast, overexpression of YTHDF2 exerted the opposite effect (Zhang et al., 2020). This evidence concerns the gene YTHDF2 and liver cancer.